The benefits of PCSK9 inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
Abstract. Background. Proprotein convertase subtilisin/kexin 9 (PSCK9) inhibitors have been beneficial for many patients with hyperlipidemia. The objective of this study was to investigate the benefit of PSCK9 inhibitors in patients with acute coronary syndrome (ACS). Methods. We systematically sear...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Health/LWW
2024-03-01
|
| Edice: | Emergency and Critical Care Medicine |
| On-line přístup: | http://journals.lww.com/10.1097/EC9.0000000000000108 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|